FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Sends Sesen Bio a Complete Response Letter

FDA issues Sesen Bio a complete response letter on its BLA for Vicineum (oportuzumab monatox-qqrs) for treating BCG-unresponsive non-muscle invasive b...

Human Drugs

CDERs Ellis Unger Retiring After 24 Years at Agency

CDER Office of Cardiology, Hematology, Endocrinology, and Nephrology director Ellis Unger retires to spend more time with family.

Federal Register

Drug User Fee Rates for FY 2022

Federal Register notice: FDA sets the rates for prescription drug user fees for fiscal year 2022.

Biologics

Pfizer, Moderna Booster Authorized for Immunocompromised

FDA amends the emergency use authorizations for both Pfizer-BioNTechs and Modernas Covid-19 vaccines to allow for the use of an additional dose in cer...

Human Drugs

Ipsen Withdraws NDA Palovarotene for More Analyses

Ipsen withdraws its NDA palovarotene, indicated for preventing heterotropic ossification as a potential treatment for people living with fibrodysplasi...

Medical Devices

SyntrFuge System Cleared for Adipose Tissue

FDA clears a Syntr Health Technologies 510(k) for the SyntrFuge System and its use in surgical specialties when the transfer of harvested adipose tiss...

Human Drugs

Researchers Get Jail Time for Falsifying Clinical Trial Data

A Florida federal judge sentences two people to jail time and restitution for participating in a conspiracy to falsify clinical trial data.

Medical Devices

CDRH Met or Exceeded Strategic Goals: Report

CDRH says it met or exceeded strategic goals in the period 2018-2020.

Human Drugs

FDA Approves Keytruda Plus Lenvima for Some Cancers

FDA approves Mercks Keytruda plus Eisais Lenvima for first-line treatment of adults with advanced renal cell cancer.

Human Drugs

FDA Orphan Drug Designation for Allogene Cancer Drug

FDA grants Allogenes ALLO-715 orphan drug status for treating multiple myeloma.